Skip to main content
Veterinary Medicines

ERYSIPRAVAC

Authorised
  • Erysipelothrix rhusiopathiae, strain R32E11, Inactivated

Product identification

Medicine name:
ERYSIPRAVAC
Active substance:
  • Erysipelothrix rhusiopathiae, strain R32E11, Inactivated
Target species:
  • Pig (male for reproduction)
  • Pig (young female)
  • Pig (sow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, strain R32E11, Inactivated
    1426.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (male for reproduction)
      • Meat and offal
        0
        day
    • Pig (young female)
      • Meat and offal
        0
        day
    • Pig (sow)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB03
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2527 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."